FDA Drug Application (021289) for BRAVELLE by FERRING

Back to FDA Applications sponsored by FERRING

Application Number021289
Product Number001
FormINJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
Dosage75 IU/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBRAVELLE
Active IngredientUROFOLLITROPIN

Active IngredientCount
List of drugs with Active Ingredient UROFOLLITROPIN3


Back to FDA Applications sponsored by FERRING